Multimodality therapy of esophageal carcinoma: still an experimental approach

Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs).

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2017

Combined modality chemoradiation in elderly oesophageal cancer patients.

British journal of cancer·2007

Phase I study of topoisomerase I inhibitor exatecan mesylate (DX-8951f) given as weekly 24-hour infusions three of every four weeks.

Clinical cancer research : an official journal of the American Association for Cancer Research·2001

Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001

Phase I clinical and pharmacologic study of weekly cisplatin combined with weekly irinotecan in patients with advanced solid tumors.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1998